Research ArticleCancer

Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers

Science Translational Medicine  08 Feb 2012:
Vol. 4, Issue 120, pp. 120ra17
DOI: 10.1126/scitranslmed.3003316

Log in to view the full text

Navigate This Article

  1. Article
    1. Abstract
    2. Introduction
    3. Results
    4. Discussion
    5. Materials and Methods
    6. Supplementary Material
    7. References and Notes
  2. Figures & Data
  3. Info & Metrics
  4. eLetters
  5. PDF